Previous Next


№3' 2021


International Medical Journal, Vol. 27., Iss. 3, 2021, P. 67−71.



Salyenkova O. A., Danyliuk S. V., Ovcharenko Yu. S.

V. N. Karazin Kharkiv National University
Kharkiv Medical Academy of Postgraduate Education, Ukraine

Hair is an important part of appearance and social communication, its loss can significantly affect psychological trauma to patients. One of the main areas of research in trichology is the study of various aspects of androgenetic alopecia. The results of the original study on the assessment of immune histochemical parameters of patients with androgenetic alopecia were analyzed in detail. Based on a study of the published reports on the pathogenesis of androgenetic alopecia, indicating the signs of perifollicular inflammation, oxidative stress and fibrosis formation as the disease progresses, immune competent T−lymphocytes CD3 +, CD4 + and CD8 +, macrophages (VEGF polyG, CDF +) were investigated thoroughly. β1, EGFR, oxidative stress enzymes eNOS and iNOS, pathological fraction of Collagen IV. Owing to the data obtained, that the cascade of pathological reactions "oxidative stress − microinflammation − fibrosis" was confirmed to be found in patients with androgenetic alopecia, and it was suggested that these links of pathogenesis could potentially be a target for therapeutic effects. Data on the results of immune histochemical examination of scalp biopsies in patientsave been presented, a and the location of certain markers to be studied, and the methodology of the study have been described. According to the biopsy results, the characteristics of inflammatory perifollicular infiltrate (CD3 +, CD4 + and CD8 +, macrophages (CD68 +), accumulation of oxidative stress enzymes (eNOS and iNOS) and imbalance of growth polypeptides (VEGF, TGF−β1, EGFla) were described. Treatment of androgenetic alopecia was concluded to be likely supplemented taking into account the imbalance of immune histochemical parameters.

Key words: androgenetic alopecia, immunohistochemistry, cytokines, growth factors, oxidative stress enzymes.


1. Ovcharenko Yu. S., Kachuk Yu. V. Androgeneticheskaya alopetsiya // Les Nouvelles Esthetiques Ukraina. 2015. № 3 (91). S. 70−78.

2. Trikhologiya / A. Zlotogorskii i dr.; pod red. A. Litusa; per. s angl. Yu. Ovcharenko. 2−e izd., dop. i pererab. K., 2016. 276 s.

3. New Insight Into the Pathophysiology of Hair Loss Trigger a Paradigm Shift in the Treatment Approach / N. S. Sadick, V. D. Callender, L. H. Kircik, S. Kogan // J. Drugs Dermatol. 2017. Vol. 16, Suppl. 11. P. 135−140.

4. Evaluation of the Expression of Genes Associated with Inflammation and Apoptosis in Androgenetic Alopecia by Targeted RNA−Seq / L. Martinez−Jacobo t al. // Skin Appendage Disord. 2018. Vol. 4. P. 268−273. doi:

5. Vascular Endothelial Growth Factor Protects CD200−Rich and CD34−Positive Hair Follicle Stem Cells Against Androgen−Induced Apoptosis Through the Phosphoinositide 3−Kinase/Akt Pathway in Patients With Androgenic Alopecia / X. Zhang, D. Zhou, T. Ma, Q. Liu // Dermatol. Surg. 2020. Vol. 46 (3). P. 358−368. doi:

6. Genetic and molecular aspects of androgenetic alopecia / L. Martinez−Jacobo et al. // Indian J. of Dermatology, Venereology and Leprology. 2018. Vol. 84 (3). P. 263−268. doi:

7. Androgenetic Alopecia Treatment in Asian Men / Y. Tanaka et al. // The J. of clinical and aesthetic dermatology. 2018. Vol. 11 (7). P. 32−35.

8. Androgenetic alopecia in males: a histopathological and ultrastructural study / M. El−Domyati, S. Attia, F. Saleh, H. Abdel−Wahab // J. of Cosmetic Dermatology. 2009. Vol. 8. P. 83−91. doi:−2165.2009.00439.x

9. Trüeb R. M. The impact of oxidative stress on hair // Int. J. Cosmet. Sci. 2015. Vol. 37. P. 25−30. doi:

10. Oxidative stress in androgenetic alopecia / B. E. Prie et al. // J. Med. Life. 2016. Vol. 9 (1). P. 79−83.

11. Differential expression between human dermal papilla cells from balding and non−balding scalps reveals new candidate genes for androgenetic alopecia / G. Y. Chew, Elaine et al. // J. of Investigative Dermatology. 2016. Vol. 136 (8). P. 1559−1567. doi:

12. Avtandilov G. G. Osnovy kolichestvennoi patologicheskoi anatomii: monogr. M.: Meditsina, 2002. 240 s.

13. Androgenetic alopecia: a review / F.Lolli et al. // Endocrine. 2017. Vol. 57 (1). P. 9−17. doi:−017−1280−y

14. Adil A., Godwin M. The effectiveness of treatments for androgenetic alopecia: a systematic review and meta−analysis // J. of the American Academy of Dermatology. 2017. Vol. 77 (1). P. 136−141. doi:

15. S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents / P. Blume et al. // Br. J. of Dermatology. 2011. Vol. 164 (1). P. 5−15. doi:−2133.2010.10011.x

16. Galliker N. A., Trüeb R. M. Value of trichoscopy versus trichogram for diagnosis of female androgenetic alopecia // Int. J. Trichology. 2012. Vol. 4 (1). P. 19−22. doi:−7753.96080

17. Gupta A. K., Carviel J. A mechanistic model of platelet−rich plasma treatment for androgenetic alopecia // Dermatologic Surgery. 2016. Vol. 42 (12). P. 1335−1339. doi:

18. The role of inflammation and immunity in the pathogenesis of androgenetic alopecia / C. M. Magro et al. // J. of drugs in dermatology: JDD. 2011. Vol. 10 (12). P. 1404−1411.

19. The role of oxidative stress in early−onset androgenetic alopecia / H. K. Erdogan et al. // J. of cosmetic dermatology. 2017. Vol. 16 (4). P. 527−530. doi:

20. Trüeb R. M. Oxidative stress in ageing of hair // International J. of trichology. 2009. Vol. 1 (1). P. 6. doi:−7753.51923

21. Utility of Horizontal Sections of Scalp Biopsies in Differentiating between Androgenetic Alopecia and Alopecia Areata / D. Yadav et al. // Dermatology. 2018. Vol. 234 (3−4). P. 137−147. doi:

22. Comparative effectiveness of low−level laser therapy for adult androgenic alopecia: a system review and meta−analysis of randomized controlled trials / K. H. Liu, D. Liu, Y. T. Chen, S. Y. Chin // Lasers Med. Sci. 2019. Vol. 34 (6). P. 1063−1069. doi:−019−02723−6

23. A Study of the Histopathological Features of Alopecias on Transverse Sections of Scalp Biopsies / M. Goyal et al. // Indian J. Dermatol. 2019. Vol. 64 (1). P. 47−54. doi:

Go on Top